Sarenthia M. Epps

Researcher

University of Arkansas for Medical Sciences

unknown

4 h-index 8 pubs 41 cited

Is this your profile? Verify and claim your profile

Biography and Research Information

OverviewAI-generated summary

Sarenthia M. Epps' research focuses on the clinical outcomes and pharmacological effects associated with critical care. Her publications investigate the association between tocilizumab and increased risks of fungal infections in critically ill COVID-19 patients, particularly those with acute renal failure. Epps has also studied tacrolimus-induced lung injury and arterial thrombus in COVID-19 infections. Her work has involved collaborations with researchers at the University of Arkansas for Medical Sciences, including Nikhil Meena, William T. Atchley, Rajani Jagana, and Barrett J. Burger, with whom she shares multiple publications. Epps' scholarly contributions include 8 publications and a citation count of 41, with an h-index of 4.

Metrics

  • h-index: 4
  • Publications: 8
  • Citations: 41

Selected Publications

  • Tocilizumab Is Associated with Increased Risk of Fungal Infections among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study (2023) DOI
  • A 34-Year-Old Man With Lightheadedness and Dyspnea (2022) DOI
  • Tocilizumab is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study. (2021) DOI
  • Tocilizumab Is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19 (2021) DOI

Collaborators

Researchers in the database who share publications

Similar Researchers

Based on overlapping research topics